Related Experiment Video
Updated: Jun 14, 2026
08:41
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Current and future therapeutic strategies in NAFLD
Nimantha Mark1, Wilfred de Alwis, Christopher Paul Day
1Faculty of Medical Sciences, Faculty Office, The Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Current Pharmaceutical Design
|April 8, 2010
Summary
Non-alcoholic fatty liver disease (NAFLD) is a growing global health issue, often linked to metabolic syndrome. Research is advancing to better understand and manage this spectrum of liver conditions, from simple fatty liver to advanced cirrhosis.
Area of Science:
- Hepatology
- Metabolic Disorders
- Gastroenterology
Background:
- Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western nations.
- NAFLD encompasses a spectrum from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis.
- NASH can progress to severe liver disease, including liver failure and hepatocellular carcinoma (HCC).
Purpose of the Study:
- To review the increasing prevalence and clinical significance of NAFLD.
- To highlight the association of NAFLD with metabolic syndrome components.
- To discuss the evolving research landscape and its impact on management strategies.
Main Methods:
- Literature review of recent clinical and basic science studies on NAFLD.
- Analysis of the disease spectrum and progression pathways.
- Examination of epidemiological trends and risk factors.
Main Results:
- NAFLD prevalence is rising globally, particularly in Western countries.
- NAFLD is strongly linked to obesity, insulin resistance, hypertension, and dyslipidemia, defining it as a liver manifestation of metabolic syndrome.
- The outcomes of NAFLD are not always benign, necessitating further investigation.
Conclusions:
- NAFLD is a significant and growing public health concern.
- Understanding the link between metabolic syndrome and NAFLD is crucial for effective management.
- Ongoing research is critical for developing improved diagnostic and therapeutic strategies for NAFLD patients.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):